Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1980-03-03
1987-09-15
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514363, 514255, 514308, 514423, 548531, 548535, 546310, A61K 3140, A61K 3141, C07D20700, C07D21172
Patent
active
046924590
ABSTRACT:
Inhibitors of angiotensin converting enzyme which have the formula: ##STR1## wherein R is hydrogen, formyl, acetyl propanoyl, butanoyl, phenylacetyl, phenylpropanoyl, benzoyl, cyclopentanecarbonyl, tert-butyloxycarbonyl, cyclopentanecarbonyl-L-lysyl, pyro-L-glutamyl-L-lysyl, L-lysyl, L-arginyl or pyro-L-glutamyl;
REFERENCES:
patent: 3832337 (1974-08-01), Ondetti et al.
patent: 3891616 (1975-06-01), Ondetti et al.
patent: 3947575 (1976-03-01), Ondetti
patent: 4046889 (1977-09-01), Ondetti et al.
patent: 4052511 (1977-10-01), Cushman et al.
patent: 4053651 (1977-10-01), Ondetti et al.
patent: 4113715 (1978-09-01), Ondetti
patent: 4154840 (1979-05-01), Ondetti et al.
Cushman, et al., Experientia, 29,1032 (1973).
Cushman, et al., Biochem., 16, 5484 (1977).
Dorer, et al., Biochem. Biophys. Acta, 429,220 (1976).
Fischer, et al., Ber. 33, 2383 (1900).
Fisher, et al., Arch. Biochem. Biophys., 189 81, (1978).
Fisher, et al., Febs. Letters, 107,273 (1979).
Gavras, et al., New England J. Med. 291, 817 (1974).
Gavras, et al., New Engl. J. Med., 298, 991 (1978).
Lehninger, Biochemistry, Worth Publishers Inc., New York, pp. 153-157 (1970).
Lipmann, Accts Chem. Res. 6,361 (1973).
Ondetti, et al., Science 196, 441 (1977).
Ryan et al., Tissue and Cell, 10, 555 (1978).
Cronyn et al., J. Am. Chem. Soc., 74,4726 (1952).
Lehninger, A., Biochemistry, Worth Publishers, Inc., New York (1975), pp. 189-195.
Ryan, J. W. et al., Biochem. J., 167,501 (1977).
Methoden der Organischen Chem. (Houben-Weyl), vol. XV, Part I, p. 376, et seq. (1974).
Methoden der Organischen Chem. (Houben-Weyl), vol. XV, Part II, p. 1 et seq. (1974).
Carter et al., J. Biol. Chem., 138, 627 (1941).
Engel et al., Proc. Soc. Exp. Biol. Med., 143, 483 (1973).
Jager et al., Chem. Ber., 103,1727 (1970).
Klosterman et al., Biochem 6,170 (1967).
Lijinski et al., Tetrahedron 26,5137 (1970).
Nagasawa et al., J. Med. Chem., 16, 583 (1973).
Pfister et al., J. Am. Chem. Soc., 71,1096 (1941).
Merrifield, Adv. Enzymol 32, 221 (1969).
Ricci et al., Annal. Biochem., 79, 610 (1977).
Oparil et al., Circ. Res. 32, 415 (1973).
Oparil et al., Circ. Res. 29, 682 (1971).
Dorer et al., Biochem J., 141, 915 (1974).
Sharpless, S. K., "Hypnotics and Sedatives", The Pharmacological Basis of Therapeutics, The Macmillan Co. (1965), pp. 105-128.
Buxton et al., J. Chem. Soc., p. 366 (1954).
Chung Alfred
Ryan James W.
Phillips Delbert R.
University of Miami
LandOfFree
Anti-hypertensive agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-hypertensive agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-hypertensive agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2158504